Searchable abstracts of presentations at key conferences in endocrinology

ea0081p723 | Thyroid | ECE2022

Metastatic papillary thyroid carcinoma without identifiable primary tumor in a patient with IgG4-related thyroiditis: challenging diagnosis and management of a rare case

Papadimitriou Kasiani , Moustaki Melpomeni′ , Tsitsimpis Anastasios , Papanikola Nektaria , Dermentzoglou Alexandros , Spanou Loukia , Vryonidou Andromahi

Introduction: IgG4-related thyroiditis (IgG4-RTD) is a rare fibroinflammatory disorder. It is characterized by dense lymphocyte infiltration (mainly IgG4+ plasma cells), enlargement and dysfunction of the thyroid gland. IgG4-RTD includes mostly cases of Hashimoto’s (HT) but also of Riedel’s and Graves’ thyroiditis. Diagnosis is set according to imaging and histopathological criteria. Papillary thyroid carcinoma (PTC) is the most common form of thyroid cancer (~9...

ea0081p248 | Late-Breaking | ECE2022

The differences between normocalcemic and hypercalcemic primary hyperparathyroidism: a tertiary center′s experience

Kalogeris Nikolaos , Papanikola Nektaria , Herolidi Eleni , Palioura Eleni , Papanikolaou Vasiliki , Loi Vasiliki , Vryonidou Andromahi

Introduction: Normocalcemic Primary Hyperparathyroidism is today considered a variant of Primary Hyperparathyroidism. It is characterized by persistently normal calcium levels and increased levels of parathyroid hormone, after the exclusion of other causes of secondary hyperparathyroidism. We aimed to compare clinical, biochemical and imaging data from patients with normocalcemic and hypercalcemic primary hyperparathyroidism. Methods: This is a retrospec...

ea0070aep226 | Bone and Calcium | ECE2020

The incidence of nephrolithiasis and osteoporosis in patients with asymptomatic hyperparathyroidism

Polymeris Antonis , Kalogeris Nikolaos , Lafkas Apostolos , Papanikola Nektaria , Herolidi Eleni , Kogia Christina , Vryonidou Andromahi

Introduction: The clinical profile of patients with primary hyperparathyroidism has changed significantly in the last decades considering the fact that most cases are asymptomatic. This could be attributed to early diagnosis due to routinely serum calcium measurement. Only 5–27% of patients present with symptoms or signs related to osteoporosis, nephrolithiasis and hypercalcaemia. However, in patients with asymptomatic primary hyperparathyroidism (APHP) data concerning t...

ea0073aep823 | Late Breaking | ECE2021

A case of euglycaemic ketoacidosis and concomitant acute pancreatitis in a diabetic patient treated with SGLT2i and GLP-1RA

Moustaki Melpomeni , Kalogeris Nikolaos , Katsafyloudi Maria , Papanikola Nektaria , Rigana Maria , Spanou Loukia , Angelopoulos Theodoros , Kalantzis Ioannis , Vryonidou Andromahi

IntroductionGlucagon-like peptide 1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) are the two novel classes of anti-diabetic agents with compelling efficacy, in terms of glucose-lowering and cardio-renal protection. Euglycemic diabetic ketoacidosis (EDKA) is a serious rare adverse effect of SLT2i while the use of GLP-1RA has been scarcely linked with acute pancreatitis in humans.Case presentatio...

ea0093oc43 | Oral communication 7: Diabetes, Obesity and Metabolism | EYES2023

Statin use and perimenopausal BMI determine the risk of incident diabetes mellitus in the postmenopause: Results of Palladia study

Mavraganis George , Papanikola Nektaria , Angelopoulou Anastasia , Stefanaki Aikaterini , Armeni Eleni , Paschou Stavroula , Anelli Valentina , Augoulea Areti , Stamatelopoulos Kimon , Lambrinoudaki Irene

Background: The menopausal transition has been associated with a heightened risk of cardiometabolic complications, including new onset diabetes mellitus (NODM). Statin-use increases the NODM-risk in the general population, however, their impact on NODM-risk specifically in postmenopausal populations has not been adequately studied.Objectives: To estimate the effect of statin-use at baseline on the risk of NODM in postmenopausal women.<p class="abstex...